Effect of lactational exposure of olanzapine on body weight of mice: A comparative study on neonates of both the sexes during post-natal development

Journal of Psychopharmacology

Volumn 24, Issue 7, 2010, Pages 1089-1096

  Mishra, A C ^a   Mohanty, B ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Body weight; Lactational exposure; Mice neonates; Olanzapine; Waist hip ratio

Indexed keywords

OLANZAPINE; PROLACTIN; RISPERIDONE;

ARTICLE; BODY WEIGHT; DRUG EFFECT; DRUG EXPOSURE; FEMALE; LACTATION; MALE; MOUSE; NEWBORN; NONHUMAN; POSTNATAL DEVELOPMENT; PRESCRIPTION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; WAIST HIP RATIO;

ANIMALS; ANIMALS, NEWBORN; ANIMALS, SUCKLING; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BODY WEIGHT; FEMALE; LACTATION; MALE; MICE; MILK; PROLACTIN; RISPERIDONE; SEX CHARACTERISTICS; WAIST-HIP RATIO; WEIGHT GAIN;

EID: 77953754701     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108100775     Document Type: Article

References (41)

1. Ader, M., Kim, SP, Catalano, KJ, Iount, V., Hucking, K., Richey, JM, et al. (2005) Metabolic dysregulation with atypical antipsychotics occurs in the absence of underlying disease. A placebo-controlled study of olanzapine and risperidone in dogs. Diabetes 54: 862-871.
2. Agrawal, P., Bhatia, MS, Malik, SC (1997) Post-partum psychosis: A clinical study. Int J Soc Psychiatry 43: 217-222.
3. Aichhorn, W., Stuppaeck, C., Whitworth, AB (2005) Risperidone and breast-feeding. J Psychopharmacol 19: 211-213.
4. Albaugh, VL, Henry, CR, Bello, NT, Hajnal, A., Lynch, SL, Halle, B., et al. (2006) Hormonal and Metabolic effects of olanzapine and clozapine related to body weight in rodents. Obesity 14: 36-51.
5. Arjona, AA, Zhang, SX, Adamson, B., Wurtman, RJ (2004) An animal model of antipsychotic-induced weight gain. Behav Brain Res 152: 121-127.
6. Baptista, T., Araujo de Baptista, E., Ying Kin, NM, Beaulieu, S., Walker, D., Joober, R., et al. (2002) Comparative effects of the antipsychotics sulpiride or risperidone in rats. I: Bodyweight, food intake, body composition, hormones and glucose tolerance. Brain Res 957: 144-151.
7. Basson, BR, Kinon, BJ, Taylor, CC, Szymanski, KA, Gilmore, JA, Tollefson, GD (2001) Factors influencing acute weight gain change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry 62: 231-238.
8. Blin, O., Micallef, J. (2001) Antipsychotic-associated weight gain and clinical outcome parameters. J Clin Psychiatry 62: 11-21.
9. Casey, DE, Zorn, SH (2001) The pharmacology of weight gain with antipsychotics. J Clin Psychiatry 62: 4-10.
10. Coccurello, R., Caprioli, A., Conti, R., Ghirardi, O., Borsini, F., Carminati, P., et al. (2008) Olanzapine but not the novel atypical antipsychotic ST2472 chronic administration induces weight gain, hyperphagia and metabolic dysregulation in mice. J Pharmacol Exp Ther 326: 905-911.
11. Cooper, GD, Harrold, JA, Halford, JCG, Goudie, AJ (2008) Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: Implications for animal models of antipsychotic-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry 32: 428-436.
12. Cooper, GD, Pickavance, LC, Wilding, JP, Halford, JC, Goudie, AJ (2005) A parametric analysis of olanzapine-induced weight gain in female rats. Psychopharmacology 181: 80-89.
13. Cooper, GD, Pickavance, LC, Wilding, JP, Harrold, JA, Halford, G., Goudie, AJ (2007) Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities. J Psychopharmacology 21: 405-413.
14. Fell, MJ, Anjum, N., Dickinson, K., Marshall, KM, Peltola, LM, Vickers, S., et al. (2007) The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. Psychopharmacology (Berl) 194: 221-231.
15. Fell, MJ, Marshall, KM, Neill, JC (2004 a) Effects of the classical antipsychotic haloperidol and atypical antipsychotic risperidone on weight gain, the oestrous cycle and uterine weight in female rats. Eur Neuropsychopharmacol 14: 385-392.
16. Fell, MJ, Williams, J., Marshall, KM, Neill, JC (2004 b) Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats. J Psychopharmacol 18: 149-155.
17. Fell, MJ, Neill, JC, Rao, C., Marshall, KM (2005) Effects of subchronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats. Psychopharmacology 182: 499-507.
18. Fiorotto, ML, Burrin, DG, Perez, M., Reeds, PJ (1991) Intake and use of milk nutrients by rat pups suckled in small, medium, or large litters. Am J Physiol Regul Integr Comp Physiol 260: 1104-1113.
19. Fleischhaker, C., Heiser, P., Hennighausen, K., Herpertz-Dahlmann, B., Holtkamp, K., Mehler-Wex, C., et al. (2007) Weight gain associated with clozapine, olanzapine and risperidone in children and adolescents. J Neural Transm 114: 273-280.
20. Freemark, M., Fleenor, D., Driscoll, P., Binart, N., Kelly, PA (2001) Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology 142: 532-537.
21. Ganguli, R., Brar, J., Ayrton, Z. (2001) Weight gain over 4 months in schizophrenia patients: a comparison of olanzapine and risperidone. Schizophr Res 49: 261-267.
22. Gardiner, SJ, Kristensen, JH, Hackett, LP, Ilett, KF, Rampono, J. (2003) Transfer of olanzapine into breast milk calculation of infant drug dose and effect on breast fed infants. Am J Psychiatry 160: 1428-1431.
23. Gerardo-Gettens, T., Moore, BJ, Stern, JS, Horwitz, BA (1989) Prolactin stimulates food intake in a dose-dependent manner. Am J Physiol Regul Integr Comp Physiol 256: R276 - R280.
24. Goldstein, DJ, Gorbin, IA, Fung, MC (2000) Olanzapine exposed pregnancies and lactation: early experience. J Clin Psychopharmacol 20: 399-403.
25. Goudie, AJ, Smith, JA, Halford, JC (2002) Characterization of olanzapine-induced weight gain in rats. J Psychopharmacol 16: 291-296.
26. Haddad, P. (2005) Weight change with atypical antipsychotics in the treatment of schizophrenia. J Psychopharmacol 19: 16-27.
27. Heiman, M., Leander, J., Breier, A. (2001) Preclinical study on the mechanisms underlying weight gain during olanzapine treatment. World J Boil Psychiatry 2: P 010 - P016.
28. Houseknecht, KL, Robertson, AS, Zavadoski, W., Gibbs, EM, Johnson, DE, Rollema, H. (2007) Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic Effects. Neuropsychopharmacology 32: 289-297.
29. Ilett, KF, Hackett, LP, Kristensen, JH, Vaddadi, KS, Gardiner, SJ, Begg, EJ (2004) Transfer of risperidone and 9-hydroxy risperidone into human milk. Ann Pharmacother 38: 273-276.
30. Kapur, S., Vanderspek, SC, Brownlee, BA, Nobrega, JN (2003) Antipsychotic dosing in preclinical models is often unrepresentative of the clinical conditions: A suggested solution based on in vivo occupancy. J Pharmacol Exp Ther 305: 625-631.
31. Kinon, BJ, Basson, BR, Gilmore, JA, Tollefson, GD (2001) Long term olanzapine treatment: weight change and weight related factors in schizophrenia. J Clin Psychiatry 62: 92-100.
32. Leander, J., Gleason, S. (2001) Preclinical studies of weight gain during olanzapine treatment. World J Boil Psychiatry 2: P 010 - P003.
33. Minet-Ringuet, J., Even, PC, Lacroix, M., Tome, D., de Beaurepaire, R. (2006) A model for antipsychotic-induced obesity in the male rat. Psychopharmacology 187: 447-454.
34. Nasrallah, H. (2003) A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 28: 83-96.
35. Newcomer, JW (2005) Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19: 1-93.
36. Pouzet, B., Mow, T., Kreilgard, M., Velschow, S. (2003) Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human. Pharmacol Biochem Behav 75: 133-140.
37. Pritchard, DB, Harris, B. (1996) Aspects of perinatal psychiatric illness. Br J Psychiatry 169: 555-562.
38. Ratzoni, G., Gothelf, D., Brand-Gothelf, A., Reidman, J., Kikinzon, L., Gal, G., et al. (2002) Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. J Am Acad Child Adolesc Psychiatry 41: 337-343.
39. Vestri, HS, Maianu, L., Moellering, DR, Garvey, WT (2007) Atypical antipsychotic drugs directly impair insulin action in adipocytes: Effects on glucose transport, lipogenesis, and antilipolysis. Neuropsychopharmacol 32: 765-772.
40. Wetterling, T. (2001) Body weight gain with atypical antipsychotics. A comparative review. Drug Saf 24: 59-73.
41. Yaeger, D., Smith, HG, Altshuler, LL (2006) Atypical Antipsychotics in the treatment of Schizophrenia during Pregnancy and the Post-partum. Am J Psychiatry 163: 2064-2070.